These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Glycosaminoglycans in urine of type 1 diabetic patients. Sindelka G; Skrha J; Stibor V; Stolba P Sb Lek; 1993; 94(1):77-80. PubMed ID: 7992002 [TBL] [Abstract][Full Text] [Related]
11. Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide. Ceriello A; Quatraro A; Marchi E; Barbanti M; Giugliano D Diabete Metab; 1993; 19(2):225-9. PubMed ID: 8339853 [TBL] [Abstract][Full Text] [Related]
12. Abnormal erythrocyte charge in diabetes mellitus. Link with microalbuminuria. Gambaro G; Baggio B; Cicerello E; Mastrosimone S; Marzaro G; Borsatti A; Crepaldi G Diabetes; 1988 Jun; 37(6):745-8. PubMed ID: 3384180 [TBL] [Abstract][Full Text] [Related]
13. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
14. Effects of imidazole-2-hydroxibenzoate on glycosaminoglycan and albumin urinary excretion in type 1 diabetic patients. Baggio B; Briani G; Cicerello E; Gambaro G; Giorato C; Iori E; Lavagnini T; Crepaldi G Nephron; 1988; 50(1):45-9. PubMed ID: 3173600 [TBL] [Abstract][Full Text] [Related]
15. The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier. Janssen DA; van Wijk XM; Jansen KC; van Kuppevelt TH; Heesakkers JP; Schalken JA J Urol; 2013 Jan; 189(1):336-42. PubMed ID: 23174248 [TBL] [Abstract][Full Text] [Related]
16. [Indicators of the condition of connective tissue and the activity of the pentose cycle of glucose metabolism in patients with diabetes mellitus]. Dozorets IuL; Okorokov AN; Bobkov VIa; Rabkin M Sov Med; 1975 Jun; (6):57-60. PubMed ID: 1162476 [No Abstract] [Full Text] [Related]
17. Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications. Lepedda AJ; De Muro P; Capobianco G; Formato M J Diabetes Complications; 2017 Jan; 31(1):149-155. PubMed ID: 27842978 [TBL] [Abstract][Full Text] [Related]
18. [Content of sulphated glycosaminoglycans in blood serum and urinary excretion of oxyproline in patients with diabetes mellitus]. Dozorets IuL; Okorokov AN; Bobkov VIa Vrach Delo; 1976 Apr; (4):92-4. PubMed ID: 1007213 [No Abstract] [Full Text] [Related]
19. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Pereira DA; Aguiar JA; Hagiwara MK; Michelacci YM Biochim Biophys Acta; 2004 Apr; 1672(1):1-11. PubMed ID: 15056487 [TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycans of human serum and their alterations in diabetes mellitus. Koźma EM; Olczyk K; Głowacki A; Komosińska K; Sonecki P; Najmiec T; Jaźwiec M Acta Biochim Pol; 1996; 43(3):567-74. PubMed ID: 8922042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]